Coming soon. It is a new 50-acre API process R&D and manufacturing site in Singapore. Phase I includes a large-scale manufacturing plant for oligonucleotides, peptides, and the related synthetic conjugates and 2 plants for small molecule API, expected to start operations in 2027.
Tuas, Singapore
Tuas, Singapore
API process development and manufacturing for small molecule, oligonucleotide and peptide
- 20 Emerald Hill Road, Singapore (229302)
- +65-62782538
Site Virtual Tour
Site Related News
WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation
SINGAPORE, July 19, 2022 – WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and he...
Read MoreWuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation
SINGAPORE, July 19, 2022 – WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and he...
Read MoreHow can we help?
Oligonucleotide or Peptide Projects?
